Comprehensive molecular pathology analysis of small bowel adenocarcinoma reveals novel targets with potential for clinical utility

Small bowel accounts for only 0.5% of cancer cases in the US but incidence rates have been rising at 2.4% per year over the past decade. One-third of these are adenocarcinomas but little is known about their molecular pathology and no molecular markers are available for clinical use. Using a retrosp...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncotarget
Hlavní autoři: Alvi, Muhammad A., McArt, Darragh G., Kelly, Paul, Fuchs, Marc-Aurel, Alderdice, Matthew, McCabe, Clare M., Bingham, Victoria, McGready, Claire, Tripathi, Shailesh, Emmert-Streib, Frank, Loughrey, Maurice B., McQuaid, Stephen, Maxwell, Perry, Hamilton, Peter W., Turkington, Richard, James, Jacqueline A., Wilson, Richard H., Salto-Tellez, Manuel
Médium: Artigo
Jazyk:Inglês
Vydáno: Impact Journals LLC 2015
Témata:
Research Paper: Pathology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4673235/
https://ncbi.nlm.nih.gov/pubmed/26315110
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky